Incruse Ellipta 62.5 (Umeclidinium Bromide POWDER) 62.5mcg

Incruse Ellipta 62.5mcg is a prescription inhaler containing umeclidinium bromide, a long-acting anticholinergic bronchodilator used for chronic obstructive pulmonary disease (COPD) maintenance. This powder formulation delivers precise dosing for once-daily respiratory relief. Shop COPD inhalers online with discreet packaging and fast shipping.

Strength

62.5mcg

Pack Size

30s

Storage

15-25°

Manufacturer / TM Owner

GlaxoSmithKline LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Incruse Ellipta 62.5mcg is used to treat chronic obstructive pulmonary disease (COPD) including chronic bronchitis and emphysema. It helps open airways by relaxing muscles around the lungs to make breathing easier. This medication is not a rescue inhaler for sudden breathing problems. It is designed for long-term daily use to manage symptoms and improve lung function over time.

Side Effects

Users of Incruse Ellipta 62.5mcg often report improved breathing comfort and reduced wheezing within the first few days of regular use. Some may notice less coughing and chest tightness, supporting easier daily activities. Effects can vary, and consistent use is important for best results. Dry mouth is a commonly reported experience.

Precautions & Warnings

Store Incruse Ellipta 62.5mcg at room temperature between 15–25°C, away from moisture and direct light. Keep the inhaler in its original sealed tray until ready to use to protect from humidity. Do not open the foil until you are ready to take a dose. Always use the inhaler as prescribed and do not share it with others.

Avoid Interactions

Incruse Ellipta 62.5mcg may interact with other anticholinergic medications, which can increase side effects like dry mouth or urinary retention. Avoid using additional inhaled medicines containing similar active ingredients unless directed by a healthcare provider. Inform your doctor about all prescription, over-the-counter, and herbal products you use.

Frequently Asked Questions

It is used to treat chronic obstructive pulmonary disease (COPD) by helping to open airways and improve breathing.

Follow the instructions provided with the inhaler. It is a once-daily maintenance inhaler that should be used at the same time each day.

No, this is not a rescue inhaler. Use a fast-acting inhaler for sudden symptoms and contact a healthcare provider if breathing problems worsen.

Common side effects may include dry mouth, sore throat, and cough. Most are mild and temporary.

No, Incruse Ellipta 62.5mcg requires a prescription from a licensed healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.